Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients

Breast cancer (BC) is not only a mass of malignant cells but also a systemic inflammatory disease. BC pro-tumorigenic inflammation has been shown to promote immune evasion and provoke BC progression. The NOD-like receptor (NLR) family pyrin domain-containing protein 3 (NLRP3) inflammasome is activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Elgohary, Sawsan, Eissa, Reda A., El Tayebi, Hend M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531892/
https://www.ncbi.nlm.nih.gov/pubmed/37762557
http://dx.doi.org/10.3390/ijms241814254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531892/
https://www.ncbi.nlm.nih.gov/pubmed/37762557
http://dx.doi.org/10.3390/ijms241814254

Ejemplares similares